 |
|
|
|
|
|
 |
Deals & Alliances |
|
|
| Title |
 |
Publication Date |
 |
Price |
|
|
|
|
Partnering with Biopharma
The definitive guide to bigpharma partnering interests, contacts & agreements
|
July 2008 |
£1495 |
Clinical Stage Partnering Agreements in Biopharma
|
June 2008 |
£1310 |
Emerging Pharmaceutical Markets Globally
|
April 2008 |
£755 |
Manufacturing & Supply Agreements in Biopharma
|
April 2008 |
£1210 |
Distribution Agreements in Biopharma
|
April 2008 |
£1210 |
Bigpharma Partnering Agreements
|
March 2008 |
£1210 |
Medicis Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Medicure Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mediware Information Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Medicines Co. -Deals & Alliances Report
|
February 2008 |
£300 |
McKesson Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Medtronic Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Medarex Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
MedcoHealth Solutions Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
MediciNova Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Merck & Co. Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Micromet, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Microsoft Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Migenix Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Merit Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Meridian Bioscience Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mentor Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Maxygen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Merge Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Meldex International Plc -Deals & Alliances Report
|
February 2008 |
£300 |
MGI Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Large Scale Biology Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Lescarden Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Let's Talk Recovery, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Lannett Co. Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Laboratory Corp. of America Holdings -Deals & Alliances Report
|
February 2008 |
£300 |
King Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Koninklijke Philips Electronics NV -Deals & Alliances Report
|
February 2008 |
£300 |
Kosan Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Lexicon Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Life Therapeutics Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
MDS, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Millennium Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Martek Biosciences Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Luminex Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Ligand Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
LifeCell Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Lifecore Biomedical Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Masimo Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Monogram Biosciences, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Novavax, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Noven Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Novo Nordisk A -Deals & Alliances Report
|
February 2008 |
£300 |
Novartis AG -Deals & Alliances Report
|
February 2008 |
£300 |
Novadel Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
NexMed Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
NitroMed Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
North American Scientific Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Novozymes A -Deals & Alliances Report
|
February 2008 |
£300 |
Nutrition 21 Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Omnicell Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Oncothyreon Inc -Deals & Alliances Report
|
February 2008 |
£300 |
Onyx Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Omnicare Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
OSI Systems, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nuvelo Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nymox Pharmaceutical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
OSI Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Neurogen Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Neurocrine Biosciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
MultiCell Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mylan, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Myriad Genetics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Motorola Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Monsanto Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Misonix Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Mitsui & Co. Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Keryx Biopharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
NPS Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nabi Biopharmaceuticals -Deals & Alliances Report
|
February 2008 |
£300 |
Neose Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nestle SA -Deals & Alliances Report
|
February 2008 |
£300 |
Neurochem Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Neoprobe Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
NeoPharm Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nanogen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nastech Pharmaceutical Company, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Nektar Therapeutics -Deals & Alliances Report
|
February 2008 |
£300 |
Millipore Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Inyx Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Illumina Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Imarx Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Imclone Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Idera Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IGI Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ICAgen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IDEXX Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IDM Pharma, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Immtech Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ImmuCell Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Incyte Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Indevus Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Integra LifeSciences Holdings Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Implant Sciences Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Immunomedics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Immucor Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Immunicon Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Immunogen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Humana Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Human Genome Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
H. Lundbeck A -Deals & Alliances Report
|
February 2008 |
£300 |
HLTH Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Haemonetics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Glaxosmithkline plc -Deals & Alliances Report
|
February 2008 |
£300 |
Gilead Sciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Genta Incorporated -Deals & Alliances Report
|
February 2008 |
£300 |
Genzyme Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Geron Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Healthways Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Helix Biomedix Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Hitachi Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Hologic Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Hospira Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Hi Tech Pharmacal Co. Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Hewlett -Packard Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Hemispherx Biopharma, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Henry Schein Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Heska Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Integrated Biopharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Interleukin Genetics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Inflazyme Pharmaceuticals Ltd -Deals & Alliances Report
|
February 2008 |
£300 |
Inhibitex Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Inovio Biomedical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Infinity Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
InNexus Biotechnology, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ISIS Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ISTA Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Impax Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Insite Vision Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Insmed Incorporated -Deals & Alliances Report
|
February 2008 |
£300 |
Opko Health, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Jazz Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Johnson & Johnson -Deals & Alliances Report
|
February 2008 |
£300 |
Invitrogen Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Intuitive Surgical, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Inspire Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
InterMune Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Introgen Therapeutics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IRIS International Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
IMS Health Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SCOLR Pharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Spectral Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
The Cooper Companies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Quest Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Natus Medical Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
International Business Machines Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Inverness Medical Innovations Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Labopharm Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
deCODE genetics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
eResearchTechnology Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Callisto Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Dr. Reddy's Laboratories Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Eli Lilly & Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Bayer Schering Pharma AG -Deals & Alliances Report
|
February 2008 |
£300 |
Allscripts Healthcare Solutions Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
etrials Worldwide, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
icad Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
3M Co. -Deals & Alliances Report
|
February 2008 |
£300 |
KV Pharmaceutical Co. -Deals & Alliances Report
|
February 2008 |
£300 |
Orthofix International NV -Deals & Alliances Report
|
February 2008 |
£300 |
Teleflex Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Telik Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Tenet Healthcare Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Techne Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Taro Pharmaceutical Industries Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Synvista Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Tapestry Pharmaceuticals -Deals & Alliances Report
|
February 2008 |
£300 |
Targeted Genetics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Teva Pharmaceutical Industries Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Theragenics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
TorreyPines Therapeutics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Transgenomic Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Trinity Biotech plc -Deals & Alliances Report
|
February 2008 |
£300 |
Titan Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Thomson Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Thermo Fisher Scientific, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Thermogenesis Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Third Wave Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Syngenta AG -Deals & Alliances Report
|
February 2008 |
£300 |
Symyx Technologies Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SpectRx Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Spectrum Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
St. Jude Medical Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Sonus Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SonoSite Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Skinvisible Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SkyePharma plc -Deals & Alliances Report
|
February 2008 |
£300 |
Smith & Nephew plc -Deals & Alliances Report
|
February 2008 |
£300 |
Starpharma Holdings Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Stellar Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SuperGen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
SurModics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Sygnis Pharma AG -Deals & Alliances Report
|
February 2008 |
£300 |
Sunesis Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Stryker Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Stem Cell Innovations, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
StemCells Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Strategic Diagnostics Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Tripos Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Tyco International Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
Watson Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
WellPoint Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
West Pharmaceutical Services Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
inVentiv Health, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Waters Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Vital Images Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Volcano Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Warner Chilcott Limited -Deals & Alliances Report
|
February 2008 |
£300 |
Women First Healthcare Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Wright Medical Group Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Zila, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Zimmer Holdings Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ZymoGenetics, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
ZOLL Medical Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
YM BioSciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Wyeth -Deals & Alliances Report
|
February 2008 |
£300 |
XOMA Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
XTL Biopharmaceuticals Ltd. -Deals & Alliances Report
|
February 2008 |
£300 |
ViroPharma Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Viragen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
VIA Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Valeant Pharmaceuticals International -Deals & Alliances Report
|
February 2008 |
£300 |
Varian Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Utek Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Unitedhealth Group, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Unigene Laboratories Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Unilever NV -Deals & Alliances Report
|
February 2008 |
£300 |
United Therapeutics Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
VaxGen Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Ventana Medical Systems Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vical Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
VioQuest Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vion Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vertex Pharmaceuticals Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Vernalis plc -Deals & Alliances Report
|
February 2008 |
£300 |
Verenium Corporation -Deals & Alliances Report
|
February 2008 |
£300 |
Vermillion, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Simulations Plus Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Sigma -Aldrich Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Phase Forward Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Phytopharm plc -Deals & Alliances Report
|
February 2008 |
£300 |
Pipex Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharsight Corp. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharming Group N.V. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharmaceutical Product Development Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharmacopeia, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pharmasset, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Poniard Pharmaceuticals, Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Pressure BioSciences Inc. -Deals & Alliances Report
|
February 2008 |
£300 |
Protherics plc -Deals & Alliances Report
|
February 2008 |
£300 |
